Go Pro

Bowhead Specialty (BOW) Competitors

Bowhead Specialty logo
$33.77 -0.03 (-0.09%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$33.77 0.00 (0.00%)
As of 10/2/2026 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BOW vs. SKWD, ARX, LMND, PLMR, and AGO

Should you buy Bowhead Specialty stock or one of its competitors? Bowhead Specialty's main competitors and comparable companies include Skyward Specialty Insurance Group (SKWD), Accelerant (ARX), Lemonade (LMND), Palomar (PLMR), and Assured Guaranty (AGO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "property & casualty insurance" industry.

How does Bowhead Specialty compare to Skyward Specialty Insurance Group?

Bowhead Specialty (NYSE:BOW) and Skyward Specialty Insurance Group (NASDAQ:SKWD) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

Skyward Specialty Insurance Group has a net margin of 10.84% compared to Bowhead Specialty's net margin of 10.11%. Skyward Specialty Insurance Group's return on equity of 18.72% beat Bowhead Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
Bowhead Specialty10.11% 14.05% 2.64%
Skyward Specialty Insurance Group 10.84%18.72%3.68%

Bowhead Specialty currently has a consensus target price of $33.50, indicating a potential downside of 0.80%. Skyward Specialty Insurance Group has a consensus target price of $70.00, indicating a potential upside of 27.25%. Given Skyward Specialty Insurance Group's stronger consensus rating and higher possible upside, analysts clearly believe Skyward Specialty Insurance Group is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bowhead Specialty
0 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.10
Skyward Specialty Insurance Group
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.91

In the previous week, Skyward Specialty Insurance Group had 1 more articles in the media than Bowhead Specialty. MarketBeat recorded 3 mentions for Skyward Specialty Insurance Group and 2 mentions for Bowhead Specialty. Skyward Specialty Insurance Group's average media sentiment score of 0.56 beat Bowhead Specialty's score of 0.33 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bowhead Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Skyward Specialty Insurance Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.8% of Skyward Specialty Insurance Group shares are owned by institutional investors. 4.2% of Bowhead Specialty shares are owned by company insiders. Comparatively, 8.5% of Skyward Specialty Insurance Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Bowhead Specialty has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market. Comparatively, Skyward Specialty Insurance Group has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market.

Skyward Specialty Insurance Group has higher revenue and earnings than Bowhead Specialty. Skyward Specialty Insurance Group is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bowhead Specialty$551.59M2.02$53.79M$1.8518.25
Skyward Specialty Insurance Group$1.42B1.72$170.03M$4.2912.82

Summary

Skyward Specialty Insurance Group beats Bowhead Specialty on 15 of the 17 factors compared between the two stocks.

How does Bowhead Specialty compare to Accelerant?

Accelerant (NYSE:ARX) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

Bowhead Specialty has a net margin of 10.11% compared to Accelerant's net margin of -113.08%. Accelerant's return on equity of 42.79% beat Bowhead Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
Accelerant-113.08% 42.79% 3.68%
Bowhead Specialty 10.11%14.05%2.64%

Accelerant has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.07, indicating that its stock price is 107% less volatile than the broader market.

In the previous week, Accelerant had 1 more articles in the media than Bowhead Specialty. MarketBeat recorded 3 mentions for Accelerant and 2 mentions for Bowhead Specialty. Bowhead Specialty's average media sentiment score of 0.33 beat Accelerant's score of 0.26 indicating that Bowhead Specialty is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accelerant
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bowhead Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Accelerant currently has a consensus target price of $17.98, suggesting a potential downside of 8.92%. Bowhead Specialty has a consensus target price of $33.50, suggesting a potential downside of 0.80%. Given Bowhead Specialty's stronger consensus rating and higher probable upside, analysts clearly believe Bowhead Specialty is more favorable than Accelerant.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accelerant
2 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Bowhead Specialty
0 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.10

Bowhead Specialty has lower revenue, but higher earnings than Accelerant. Accelerant is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accelerant$912.90M4.70-$1.35B-$6.65N/A
Bowhead Specialty$551.59M2.02$53.79M$1.8518.25

Summary

Accelerant and Bowhead Specialty tied by winning 7 of the 14 factors compared between the two stocks.

How does Bowhead Specialty compare to Lemonade?

Bowhead Specialty (NYSE:BOW) and Lemonade (NYSE:LMND) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Bowhead Specialty has a net margin of 10.11% compared to Lemonade's net margin of -14.19%. Bowhead Specialty's return on equity of 14.05% beat Lemonade's return on equity.

Company Net Margins Return on Equity Return on Assets
Bowhead Specialty10.11% 14.05% 2.64%
Lemonade -14.19%-26.78%-7.08%

Bowhead Specialty currently has a consensus target price of $33.50, indicating a potential downside of 0.80%. Lemonade has a consensus target price of $64.50, indicating a potential upside of 39.02%. Given Lemonade's stronger consensus rating and higher probable upside, analysts clearly believe Lemonade is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bowhead Specialty
0 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.10
Lemonade
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

Bowhead Specialty has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, Lemonade has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market.

In the previous week, Lemonade had 3 more articles in the media than Bowhead Specialty. MarketBeat recorded 5 mentions for Lemonade and 2 mentions for Bowhead Specialty. Lemonade's average media sentiment score of 0.40 beat Bowhead Specialty's score of 0.33 indicating that Lemonade is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bowhead Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Lemonade
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bowhead Specialty has higher earnings, but lower revenue than Lemonade. Lemonade is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bowhead Specialty$551.59M2.02$53.79M$1.8518.25
Lemonade$737.90M4.87-$165.50M-$1.83N/A

80.3% of Lemonade shares are held by institutional investors. 4.2% of Bowhead Specialty shares are held by company insiders. Comparatively, 12.2% of Lemonade shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Lemonade beats Bowhead Specialty on 10 of the 16 factors compared between the two stocks.

How does Bowhead Specialty compare to Palomar?

Palomar (NASDAQ:PLMR) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Palomar currently has a consensus target price of $162.75, indicating a potential upside of 28.67%. Bowhead Specialty has a consensus target price of $33.50, indicating a potential downside of 0.80%. Given Palomar's stronger consensus rating and higher probable upside, research analysts clearly believe Palomar is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Palomar
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
Bowhead Specialty
0 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.10

Palomar has a net margin of 18.61% compared to Bowhead Specialty's net margin of 10.11%. Palomar's return on equity of 23.28% beat Bowhead Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
Palomar18.61% 23.28% 6.45%
Bowhead Specialty 10.11%14.05%2.64%

Palomar has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.07, indicating that its share price is 107% less volatile than the broader market.

In the previous week, Palomar had 8 more articles in the media than Bowhead Specialty. MarketBeat recorded 10 mentions for Palomar and 2 mentions for Bowhead Specialty. Palomar's average media sentiment score of 0.61 beat Bowhead Specialty's score of 0.33 indicating that Palomar is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Palomar
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bowhead Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.3% of Palomar shares are owned by institutional investors. 3.7% of Palomar shares are owned by company insiders. Comparatively, 4.2% of Bowhead Specialty shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Palomar has higher revenue and earnings than Bowhead Specialty. Palomar is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palomar$875.97M3.80$197.07M$7.4417.00
Bowhead Specialty$551.59M2.02$53.79M$1.8518.25

Summary

Palomar beats Bowhead Specialty on 15 of the 17 factors compared between the two stocks.

How does Bowhead Specialty compare to Assured Guaranty?

Assured Guaranty (NYSE:AGO) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Assured Guaranty has higher revenue and earnings than Bowhead Specialty. Assured Guaranty is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Assured Guaranty$1.11B2.71$503M$7.509.12
Bowhead Specialty$551.59M2.02$53.79M$1.8518.25

Assured Guaranty has a net margin of 37.34% compared to Bowhead Specialty's net margin of 10.11%. Bowhead Specialty's return on equity of 14.05% beat Assured Guaranty's return on equity.

Company Net Margins Return on Equity Return on Assets
Assured Guaranty37.34% 7.11% 3.25%
Bowhead Specialty 10.11%14.05%2.64%

92.2% of Assured Guaranty shares are held by institutional investors. 5.7% of Assured Guaranty shares are held by company insiders. Comparatively, 4.2% of Bowhead Specialty shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Assured Guaranty presently has a consensus target price of $91.00, suggesting a potential upside of 33.08%. Bowhead Specialty has a consensus target price of $33.50, suggesting a potential downside of 0.80%. Given Assured Guaranty's stronger consensus rating and higher probable upside, equities research analysts clearly believe Assured Guaranty is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Assured Guaranty
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Bowhead Specialty
0 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.10

Assured Guaranty has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market.

In the previous week, Assured Guaranty had 4 more articles in the media than Bowhead Specialty. MarketBeat recorded 6 mentions for Assured Guaranty and 2 mentions for Bowhead Specialty. Assured Guaranty's average media sentiment score of 0.66 beat Bowhead Specialty's score of 0.33 indicating that Assured Guaranty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Assured Guaranty
0 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Bowhead Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Assured Guaranty beats Bowhead Specialty on 14 of the 16 factors compared between the two stocks.

Get Bowhead Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BOW vs. The Competition

MetricBowhead SpecialtyInsurance IndustryFinance SectorNYSE Exchange
Market Cap$1.11B$18.23B$13.40B$22.63B
Dividend YieldN/A3.29%6.03%3.73%
P/E Ratio18.2516.0824.4927.75
Price / Sales1.8130.29498.8117.18
Price / Cash19.7511.7046.4538.88
Price / Book2.471.992.704.64
Net Income$53.79M$1.80B$1.32B$1.08B
7 Day Performance-0.16%-1.43%-1.04%-1.06%
1 Month Performance0.18%-5.67%0.37%-5.49%
1 Year Performance33.68%5.77%11.53%5.13%

Bowhead Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BOW
Bowhead Specialty
2.6792 of 5 stars
$33.77
-0.1%
$33.50
-0.8%
+41.6%$1.11B$615.14M18.25296
SKWD
Skyward Specialty Insurance Group
3.9607 of 5 stars
$53.48
-0.2%
$70.00
+30.9%
+20.1%$2.38B$1.42B12.47611
ARX
Accelerant
1.7372 of 5 stars
$19.74
0.0%
$18.95
-4.0%
+39.3%$4.29B$912.90MN/A862
LMND
Lemonade
2.3321 of 5 stars
$44.70
+1.8%
$64.50
+44.3%
-12.9%$3.40B$737.90MN/A1,282
PLMR
Palomar
4.8129 of 5 stars
$123.14
+0.1%
$162.75
+32.2%
+12.6%$3.24B$1.09B16.55439

Related Companies and Tools


This page (NYSE:BOW) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners